NASDAQ:ZIVO ZIVO Bioscience 11/13/2026 Earnings Results & Report $5.50 -0.26 (-4.51%) As of 03:27 PM Eastern ZIVO Bioscience was expected to report earnings on November 13, 2026. Analysts expected earnings of -$0.26 per share on revenue of $351 thousand. Confirmed results have not been posted yet. This page will update with the reported figures, conference call transcript, and earnings documents as they become available. Research:Profile Earnings Announcement Details Announcement DateNovember 13, 2026 ZIVO Bioscience EPS ResultsActual EPSN/AConsensus EPS -$0.26Beat/MissN/AOne Year Ago EPSN/AZIVO Bioscience Revenue ResultsActual RevenueN/AExpected Revenue$351 thousandBeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesCompany Profile ZIVO Bioscience Earnings FAQ When is ZIVO Bioscience's next earnings date? ZIVO Bioscience's next earnings date is estimated for Wednesday, December 2, 2026. MarketBeat tracks confirmed and estimated earnings dates for ZIVO Bioscience on the company's earnings history page. ZIVO Bioscience Earnings HeadlinesZivo Bioscience, Inc. Announces Transition to OTCID MarketplaceMay 12, 2026 | businesswire.comZivo Bioscience Inc. WtApril 11, 2026 | barrons.comYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.November 17 at 1:00 AM | Reagan Gold Group (Ad)ZIVO Bioscience Provides Special Letter to ShareholdersMarch 27, 2026 | businesswire.comMaxim Group Reaffirms Their Hold Rating on Zivo Bioscience (ZIVO)December 15, 2025 | theglobeandmail.comZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic BusinessesSeptember 10, 2025 | businesswire.comSee More ZIVO Bioscience Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like ZIVO Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ZIVO Bioscience and other key companies, straight to your email. Email Address About ZIVO BioscienceZIVO Bioscience (NASDAQ:ZIVO) is a biotechnology company that develops products based on proprietary algal strains, biomass and bioactive compounds. Its research programs target applications in animal health and human health and wellness. In animal health, the company has focused on developing an algae-derived feed ingredient for poultry, including research into supporting poultry health. ZIVO has also investigated potential human-health applications for compounds derived from its algae. These are development programs, rather than a broad portfolio of established commercial products. The company was formerly known as Z Trim Holdings, Inc. and adopted the ZIVO Bioscience name as it shifted its focus toward biotechnology and algae-based research. ZIVO is based in the United States.View ZIVO Bioscience ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its YearThe Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to WatchTyson Foods' Earnings Beat Hides a Warning for Consumer Staples Dividend InvestorsMongoDB's Biggest Advantage May Be GitLab's Biggest WeaknessMicrosoft's Outage Barely Moved Its Stock, But a Bigger Risk May Be BuildingTyson Foods' 10% Surge Puts a Breakout in Sight, But Wall Street Remains CautiousOndas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog? Upcoming Earnings Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026)Ross Stores (11/19/2026)Walmart (11/19/2026)Intuit (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.